(lp0
S'GenVec Signs Option Agreement for Gene Editing and Cell Targeting Technology ... PR Newswire  - Jan 5, 2017 GAITHERSBURG, Md., Jan. 5, 2017 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that it has entered into an exclusive option agreement with Washington University in St. Louis to license&nbsp;...'
p1
aS'Intrexon to acquire fellow Md. biotech Washington Business Journal - Jan 24, 2017 Germantown-based Intrexon Corp. is swallowing up its fellow Montgomery County biotech, GenVec Inc., a small Gaithersburg gene therapy company that has been struggling to grow since its lead cancer drug candidate failed in late-stage trials in 2010.GenVec Inc.  Is Up Sharply After Bought By Intrexon - RTT NewsIntrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform - PR Newswire '
p2
aS'GenVec Inc  Is Another Low Float Runner Insider Financial - Jan 11, 2017 Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes.'
p3
aS"Here's Who Just Picked Up Genvec Inc.  Shares Small Cap Exclusive  - Feb 17, 2017 For those not familiar with the company, GenVec, Inc.  is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines."
p4
aS'6.58 MarketWatch - Dec 21, 2009 GenVec Inc. NASDAQ: GNVC. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p5
aS"GenVec Inc. GNVC  Wall Street Journal - Feb 12, 2011 P/E Ratio : The Price to Earnings  ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period ..."
p6
aS'GenVec, Inc. , Interview with Doug Swirsky, CEO Nasdaq - Feb 24, 2015 GenVec is a pioneer in the design, testing and manufacture of adenovectored product candidates that can deliver on the promise of gene-based medicine.'
p7
aS'GenVec Provides Update on Hearing Loss Clinical Program PR Newswire  - May 2, 2016 GAITHERSBURG, Md., May 2, 2016 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that it was notified by its collaborator Novartis that the Data Safety Monitoring Board  for the Phase 1/2&nbsp;...'
p8
aS'Lifshitz &amp; Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc ... PR Newswire  - Feb 17, 2017 Lifshitz &amp; Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs.'
p9
aS'200% Gain For GenVec In Sight Following January 5 Announcement Benzinga - Jan 10, 2017 Shares of GenVec Inc  are set to record 200-percent gains after signing an option deal last week with Washington University in St. Louis.GenVec, Inc.  Posts Big Gains - StockNewsUnion'
p10
a.